VIDEO: Planned Parenthood Sells “Viable” Healthy 6-Month-Old Babies to University of California
Planned Parenthood staff on camera laughing over ripping legs off of viable, live preborn babies
Study Registration Documents Seeking Healthy, Viable 23-Week Fetuses From Elective Abortions at Planned Parenthood Revealed in Ongoing Public Records Requests to UCSD.
SAN DIEGO, Nov. 21, 2024—Never-before-seen documents released under a California public records request show Planned Parenthood supplying “viable nonanomalous” fetuses up to 23 weeks old from elective abortions to UC San Diego, as part of its contract to sell the University “proprietary” “fetal material” in exchange for the “valuable consideration” of owning any “patents” and “intellectual property” developed experimenting with them.
The shocking new admissions begin in a heavily-redacted Research Plan submitted to the UCSD Institutional Review Board (IRB) and approved in 2018. On page 3 of the IRB submission, the UCSD research lab writes, “We will collect tissues from fetuses ranging from 4 to 23 weeks gestational age from subjects undergoing elective surgical pregnancy termination at Planned Parenthood in San Diego” and that patients with “viable nonanomalous” fetuses will be enrolled. The majority of healthy infants born at 23 weeks can survive with modern medical care.
The IRB submission further states that clinical data collected for each subject will include “evidence of fetal heart activity by ultrasound immediately prior to the dilation and evacuation procedure”. The study sought to harvest fetuses from up to 2,500 patients.
In emails contemporaneous with the Research Plan, a harvesting worker writes, “[A]ny sample greater than about 12.5w[eeks] requires the use of a dilating medication which is given to the patients 3 hours ahead of their procedure (these are called “cyto” patients).” “Cyto” is short for Cytotec, or Misoprostol, which is the same drug used in chemical abortions to force-start labor contractions.
Planned Parenthood has been providing “viable nonanomalous” babies killed in “elective abortions” to the University of California San Diego (UCSD) for experimentation, according to a new report.
Published by The Center for Medical Progress (CMP), the emails detail a “Research Plan” that documents the harvesting of babies for experimentation on their bodies. The plan was submitted to and approved by UCSD’s Institutional Review Board (IRB) in 2018. The heavily redacted communications were obtained by the group via open records request.
According to the records reported by CMP, researchers unveiled plans in their submission to “collect tissues from fetuses ranging from 4 to 23 weeks gestational age from subjects undergoing elective surgical pregnancy termination at Planned Parenthood in San Diego.” The researchers further noted that patients with “viable nonanomalous … fetuses” would partake in the analysis.
Planned Parenthood will gather “evidence of fetal heart activity by ultrasound immediately prior to the dilation and evacuation procedure,” the submitted plan reads. The abortion provider aimed to harvest babies from “up to 2,500 patients,” according to the plan.
As noted by CMP, the “majority of healthy infants born at 23 weeks can survive with modern medical care.”
The investigative nonprofit highlighted one 2018 email indicating Planned Parenthood’s overuse of misoprostol (Cytotec) on patients hours before harvesting the viable babies for their body parts. According to CMP, the drug is often “used in chemical abortions to force-start labor contractions.”
AUTHOR
Pamela Geller
EDITORS NOTE: This Geller Report is republished with permission. ©All rights reserved.
Leave a Reply
Want to join the discussion?Feel free to contribute!